Cara Therapeutics Inc (CARA) Future Price to Earnings

Official company branding of Cara Therapeutics Inc. (CARA)

The 12-month forward P/E for Cara Therapeutics, Inc. (CARA) reflects the asset's valuation dynamics, with this metric reaching 0.00. The financial stability of Cara Therapeutics, Inc. (CARA) is based on royalties from renal itch treatments, which minimizes costs. Optimized raw material supply chains prevent disruptions in testing, although management is currently aggressively cutting expenses while revising the development strategy for its key assets.

CARA - Cara Therapeutics Inc. Forward P/E Multiple over the range 07/04/2022 - 11/18/2026

Comprehensive metric breakdowns and analytics for Cara Therapeutics, Inc. (CARA)

Fundamental valuation:caratherapeutics.com
Product sample of Cara Therapeutics Inc

The development of innovative drugs by Cara Therapeutics, Inc. (CARA) is complicated by geopolitical instability, which hinders international clinical trials and disrupts the logistics of biomaterials. By analyzing the history of the company's forward P/E ratio, an investor correlates current market capitalization with projected earnings, allowing for an assessment of the asset's fair value while accounting for overpayment risks and the impact of external shocks on long-term business profitability.

Competitors of Cara Therapeutics, Inc. (CARA)

Forward P/E Multiple BIIB|NBIX - Projected Price to Earnings Ratio|Forward P/E Multiple RGC (Regencell Bioscience Ltd)|Market Cap to Projected Earnings axsome.com (AXSM)|ACADIA Pharmaceuticals Inc - Forward P/E Multiple|Projected Price to Earnings Ratio Xenon Pharmaceuticals Inc.|Viking Therapeutics (VKTX) - Future Price to Earnings|Supernus Corp - Future Price to Earnings Multiple|Projected Price to Earnings CPRX|Denali Therapeutics Inc. (DNLI) - Market Cap to Projected Earnings|Projected Price to Earnings HRMY (Harmony Corp)|BHVN - Projected Price to Earnings Ratio|Future Price to Earnings Amylyx Pharmaceuticals, Inc. AMLX|Future Price to Earnings Multiple TRVI|PRAX - Future Price to Earnings|Market Cap to Projected Earnings Anavex Life Sciences AVXL|CBLL: Forward P/E Multiple|Projected Price to Earnings Prothena Corporation PLC|ALEC (alector.com) - Forward P/E Multiple|Projected Price to Earnings Annexon, Inc. (ANNX)|Future Price to Earnings Omeros Corporation (OMER)|Neurogene Inc. - Price to Future Earnings Ratio|acimmune.com - Projected Price to Earnings|Forward P/E Multiple Voyager Therapeutics Inc VYGR|NMRA - Future Price to Earnings|Forward Price to Earnings Multiple Scilex Holding Company (SCLX)|Tevogen Bio Holdings (TVGN) - Future Price to Earnings|Price to Future Earnings Ratio ACOG|Future Price to Earnings Cognition Therapeutics, Inc.|Inhibikase Therapeutics, Inc. - Price to Expected Earnings Ratio|Projected Price to Earnings SAVA (Cassava)|Market Cap to Projected Earnings Assertio Therapeutics|Coya Therapeutics, Inc. - Projected Price to Earnings|Market Cap to Future Earnings Ratio VTGN (VistaGen Therapeutics Inc)|Ovid Therapeutics Inc - Forward P/E Multiple|Acumen Pharmaceuticals, Inc. (ABOS) - Projected Price to Earnings|CRVO (CervoMed, Inc.) - Projected Price to Earnings|Projected Price to Earnings Alterity Therapeutics Ltd|Future Price to Earnings Clene Inc.|PepGen Inc. - Price to Expected Earnings Ratio|Projected Price to Earnings JUNS (Jupiter Neurosciences Inc)|Future Price to Earnings RLMD (Relmada Therapeutics Inc)|Annovis Bio Inc - Projected Price to Earnings|Market Cap to Projected Earnings Grace Tx (GRCE)|fireflyneuro.com - Forward P/E Multiple|Klotho Neurosciences (KLTO) - Projected Price to Earnings|NeuroSense Therapeutics, Ltd. (NRSN) - Future Price to Earnings|Price to Expected Earnings Ratio RVPH (Reviva Pharmaceuticals Holdings, Inc.)|MTVA (MetaVia) - Forward P/E Multiple|NRXS: Future Price to Earnings Multiple|Forward P/E Multiple HSDT|Forward P/E Multiple Passage Bio Inc. (PASG)|Future Price to Earnings bionomics.com.au NEUP|Forward P/E Multiple Minerva Neurosciences Inc NERV|ATHA: Projected Price to Earnings|ADXN (Addex Therapeutics, Ltd.) - Price to Future Earnings Ratio|Alzamend Neuro Inc. (ALZN) - Future Price to Earnings|Cyclerion - Future Price to Earnings Multiple|Future Price to Earnings protagenic.com|Pasithea Therapeutics - Price to Expected Earnings Ratio|Projected Price to Earnings CRGT (Cortigent, Inc.)|Avenue Therapeutics - Price to Future Earnings Ratio|Future Price to Earnings Brainstorm Cell BCLI|CHRO - Projected Price to Earnings|ELYM: Projected Price to Earnings|Market Cap to Projected Earnings Intra-Cellular Therapies, Inc. ITCI|Longboard Pharma (LBPH) - Future Price to Earnings|Marinus - Future Price to Earnings Multiple|Future Price to Earnings NKGen Biotech Inc|NRBO: Future Price to Earnings Multiple|Projected Price to Earnings SAGE (Sage Therapeutics, Inc.)|Market Cap to Projected Earnings Neurotrope|Future Price to Earnings Trevena, Inc. TRVN|Vigil Neuroscience (VIGL) - Projected Price to Earnings Ratio|WENA: Projected Price to Earnings|Future Price to Earnings Multiple CERE (Cerevel Therapeutics)